Registered entities
Cidara Therapeutics, Inc.
Reg. No. 461537286United States
Innovation
45 patent families (10 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 2,522 times.
| Year | Filings |
|---|---|
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 12 |
| 2019 | 11 |
| 2020 | 14 |
| 2021 | 11 |
| 2022 | 14 |
| 2023 | 15 |
| 2024 | 14 |
| 2025 | 9 |
| 2026 | 4 |
Social engagement
Social engagement: 9.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
25 investors on record; lead investors include RA Capital Management, CAM Capital, Fidelity Investments, Perceptive Advisors; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 32% |
| Private equity | 7 | 28% |
| Bank & private debt | 1 | 4% |
| Other / undisclosed | 9 | 36% |
Recent activity
24 Nov 2025
Milestone
regulatory
23 Oct 2025
Event
10th Influenza Conference
13 Oct 2025
Event
IDWeek